Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX (PHOENIX)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03366337
Recruitment Status : Completed
First Posted : December 8, 2017
Last Update Posted : December 24, 2019
Sponsor:
Information provided by (Responsible Party):
Reata Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 2, 2019
Actual Study Completion Date : January 29, 2019
Certification/Extension First Submitted : December 20, 2019